{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:30:07Z","timestamp":1786980607742,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Beijing Natural Science Fund of China","award":["7232352"],"award-info":[{"award-number":["7232352"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Fund of China","doi-asserted-by":"crossref","award":["82371985"],"award-info":[{"award-number":["82371985"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To utilize machine learning techniques to screen contrast-enhanced ultrasound (CEUS) parameters and clinical characteristics, aiming to differentiate diabetic nephropathy (DN) from non-diabetic renal disease (NDRD) in patients with diabetic kidney injury.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data from 120 diabetic patients (240 kidneys) with chronic kidney disease (CKD) were analyzed. The data included basic clinical features for each kidney and renal vascular data obtained through CEUS. Statistical analysis, tenfold cross-validation and random forest method were used for data processing. Receiver operating characteristic (ROC) curves were employed to depict the diagnostic performance of the indicators.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The random forest model integrating CEUS parameters and clinical characteristics achieved an average classification accuracy of 87.6% in differentiating kidney injury types. ROC curve analysis showed an AUC of 0.918.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Through machine learning, CEUS quantitative parameters and clinical features of the screened model can be used as important noninvasive biomarkers to identify kidney injury in T2DM patients with DN. Ai-assisted CEUS and specific clinical features are a fast and reliable tool for DN screening.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10238-025-01837-2","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T06:34:11Z","timestamp":1761892451000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Reliable biomarkers for diabetic nephropathy using machine learning-assisted contrast-enhanced ultrasonography and clinical characteristics"],"prefix":"10.1007","volume":"25","author":[{"given":"Lin","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiru","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukun","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"key":"1837_CR1","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","volume":"105","author":"PE Stevens","year":"2024","unstructured":"Stevens PE, Ahmed SB, Carrero JJ, et al. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105:S117\u2013314.","journal-title":"Kidney Int"},{"key":"1837_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102614","author":"GM Chertow","year":"2024","unstructured":"Chertow GM, Correa-Rotter R, Eckardt K-U, et al. Projecting the clinical burden of chronic kidney disease at the patient level (Inside CKD): a microsimulation modelling study. eClin Med. 2024. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102614.","journal-title":"eClin Med"},{"key":"1837_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e38835","author":"Y Wen","year":"2025","unstructured":"Wen Y, Gan H, Zhong Q, Gong Y. Long noncoding RNA Gm4419 promotes mesangial cell proliferation and extracellular matrix accumulation via the miR-455-3p\/histone deacetylase 2 axis. Heliyon. 2025. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e38835.","journal-title":"Heliyon"},{"key":"1837_CR4","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s11255-020-02657-x","volume":"53","author":"M Li","year":"2020","unstructured":"Li M, Li C-m, Ye Z-c, Rao J-l, Peng H, Lou T-q. A retrospective cohort study on the pathology and outcomes of type 2 diabetic patients with renal involvement. Int Urol Nephrol. 2020;53:333\u201341.","journal-title":"Int Urol Nephrol"},{"key":"1837_CR5","doi-asserted-by":"publisher","first-page":"151142","DOI":"10.1016\/j.bbrc.2024.151142","volume":"744","author":"W Zhang","year":"2025","unstructured":"Zhang W, Zhang Y, Lv W, Kong Z, Wang F, Wang Y. Isoquercitrin improves diabetes nephropathy by inhibiting the sodium-glucose co-transporter-2 pathway. Biochem Biophys Res Commun. 2025;744:151142.","journal-title":"Biochem Biophys Res Commun"},{"key":"1837_CR6","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.kint.2022.05.012","volume":"102","author":"KR Tuttle","year":"2022","unstructured":"Tuttle KR, Agarwal R, Alpers CE, et al. Molecular mechanisms and therapeutic targets for diabetic kidney disease. Kidney Int. 2022;102:248\u201360.","journal-title":"Kidney Int"},{"key":"1837_CR7","first-page":"9","volume":"10","author":"S Khedr","year":"2024","unstructured":"Khedr S, Dissanayake LV, Alsheikh AJ, et al. Role of cGAS\/STING pathway in aging and sexual dimorphism in diabetic kidney disease. JCI Insight. 2024;10:9.","journal-title":"JCI Insight"},{"key":"1837_CR8","first-page":"5","volume":"21","author":"N Samsu","year":"2021","unstructured":"Samsu N, Bellini MI. Diabetic nephropathy: challenges in pathogenesis, diagnosis, and treatment. BioMed Res Int. 2021;21:5.","journal-title":"BioMed Res Int"},{"key":"1837_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10030457","author":"S Park","year":"2021","unstructured":"Park S, Hong M, Lee H, et al. New model for predicting the presence of coronary artery calcification. J Clin Med. 2021. https:\/\/doi.org\/10.3390\/jcm10030457.","journal-title":"J Clin Med"},{"key":"1837_CR10","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/sam.11498","volume":"14","author":"A Mantero","year":"2021","unstructured":"Mantero A, Ishwaran H. Unsupervised random forests. Stat Anal Data Min ASA Data Sci J. 2021;14:144\u201367.","journal-title":"Stat Anal Data Min ASA Data Sci J"},{"key":"1837_CR11","doi-asserted-by":"publisher","DOI":"10.4103\/ijn.IJN_424_17","author":"S Raju","year":"2020","unstructured":"Raju S, Chandragiri S, Mandarapu S, Goli R, Nimmagadda S, Uppin M. A clinicopathological study of 267 patients with diabetic kidney disease based on the renal pathology society\u20142010 classification system. Indian J Nephrol. 2020. https:\/\/doi.org\/10.4103\/ijn.IJN_424_17.","journal-title":"Indian J Nephrol"},{"key":"1837_CR12","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1681\/ASN.2010010010","volume":"21","author":"TWC Tervaert","year":"2010","unstructured":"Tervaert TWC, Mooyaart AL, Amann K, et al. Pathologic classification of diabetic nephropathy. J Am Soc Nephrol. 2010;21:556\u201363.","journal-title":"J Am Soc Nephrol"},{"key":"1837_CR13","doi-asserted-by":"publisher","first-page":"e2459348","DOI":"10.1001\/jamanetworkopen.2024.59348","volume":"8","author":"FJ Pasquel","year":"2025","unstructured":"Pasquel FJ, Davis GM, Huffman DM, et al. Automated insulin delivery in adults with type 2 diabetes: a nonrandomized clinical trial. JAMA Netw Open. 2025;8:e2459348.","journal-title":"JAMA Netw Open"},{"key":"1837_CR14","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.2215\/CJN.11491116","volume":"12","author":"RZ Alicic","year":"2017","unstructured":"Alicic RZ, Rooney MT, Tuttle KR. Diabetic kidney disease: challenges, progress, and possibilities. Clin J Am Soc Nephrol. 2017;12:2032\u201345.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1837_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-87972-8","author":"Z Xu","year":"2021","unstructured":"Xu Z, Li Z, Guo M, Bian H, Niu T, Wang J. Application of three-dimensional visualization fused with ultrasound for percutaneous renal puncture. Sci Rep. 2021. https:\/\/doi.org\/10.1038\/s41598-021-87972-8.","journal-title":"Sci Rep"},{"key":"1837_CR16","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1590\/S1677-5538.IBJU.2014.0586","volume":"41","author":"CJ Chan","year":"2015","unstructured":"Chan CJ, Srougi V, Tanno FY, Jord\u00e3o RD, Srougi M. Percutaneous puncture of renal calyxes guided by a novel device coupled with ultrasound. Int Braz J Urol. 2015;41:953\u20138.","journal-title":"Int Braz J Urol"},{"key":"1837_CR17","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/1753-0407.12994","volume":"12","author":"L Li","year":"2019","unstructured":"Li L, Yang Y, Zhu X, et al. Design and validation of a scoring model for differential diagnosis of diabetic nephropathy and nondiabetic renal diseases in type 2 diabetic patients. J Diabetes. 2019;12:237\u201346.","journal-title":"J Diabetes"},{"key":"1837_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbad002","author":"J Hu","year":"2023","unstructured":"Hu J, Szymczak S. A review on longitudinal data analysis with random forest. Brief Bioinform. 2023. https:\/\/doi.org\/10.1093\/bib\/bbad002.","journal-title":"Brief Bioinform"},{"key":"1837_CR19","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1097\/MNH.0000000000000664","volume":"30","author":"NM Selby","year":"2021","unstructured":"Selby NM, Williams JP, Phillips BE. Application of dynamic contrast enhanced ultrasound in the assessment of kidney diseases. Curr Opin Nephrol Hypertens. 2021;30:138\u201343.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"1837_CR20","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1002\/jum.15516","volume":"40","author":"Y Wang","year":"2021","unstructured":"Wang Y, Li N, Tian X, et al. Evaluation of renal microperfusion in diabetic patients with kidney injury by contrast-enhanced ultrasound. J Ultrasound Med. 2021;40:1361\u20138.","journal-title":"J Ultrasound Med"},{"key":"1837_CR21","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.57022","author":"A Anwar","year":"2024","unstructured":"Anwar A, Faisal F, Elahi W, et al. Correlation of blood urea and creatinine levels with thiamin levels in type 1 and type 2 diabetic patients. Cureus. 2024. https:\/\/doi.org\/10.7759\/cureus.57022.","journal-title":"Cureus"},{"key":"1837_CR22","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.kint.2022.10.030","volume":"103","author":"S Rayego-Mateos","year":"2023","unstructured":"Rayego-Mateos S, Rodrigues-Diez RR, Fernandez-Fernandez B, et al. Targeting inflammation to treat diabetic kidney disease: the road to 2030. Kidney Int. 2023;103:282\u201396.","journal-title":"Kidney Int"},{"key":"1837_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25063168","author":"M Nugnes","year":"2024","unstructured":"Nugnes M, Baldassarre M, Ribichini D, et al. Association between albumin alterations and renal function in patients with type 2 diabetes mellitus. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25063168.","journal-title":"Int J Mol Sci"},{"key":"1837_CR24","doi-asserted-by":"publisher","first-page":"8205","DOI":"10.12998\/wjcc.v10.i23.8205","volume":"10","author":"B Yang","year":"2022","unstructured":"Yang B, Zhao X-H, Ma G-B. Role of serum \u03b22-microglobulin, glycosylated hemoglobin, and vascular endothelial growth factor levels in diabetic nephropathy. World J Clin Cases. 2022;10:8205\u201311.","journal-title":"World J Clin Cases"},{"key":"1837_CR25","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/dom.15347","volume":"26","author":"T Uemura","year":"2024","unstructured":"Uemura T, Nishimoto M, Eriguchi M, et al. Utility of serum \u03b22-microglobulin for prediction of kidney outcome among patients with biopsy-proven diabetic nephropathy. Diabetes Obes Metab. 2024;26:583\u201391.","journal-title":"Diabetes Obes Metab"},{"key":"1837_CR26","doi-asserted-by":"publisher","first-page":"227","DOI":"10.11613\/BM.2023.030501","volume":"33","author":"L Smir\u010di\u0107 Duvnjak","year":"2023","unstructured":"Smir\u010di\u0107 Duvnjak L, Bo\u017ei\u010devi\u0107 S, Vu\u010di\u0107 Lovren\u010di\u0107 M. Diagnostic challenges of diabetic kidney disease. Biochem Med Zagreb. 2023;33:227\u201341.","journal-title":"Biochem Med Zagreb"},{"key":"1837_CR27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.7326\/0003-4819-147-1-200707030-00004","volume":"147","author":"V Menon","year":"2007","unstructured":"Menon V, Shlipak MG, Wang X, et al. Cystatin C as a risk factor for outcomes in chronic kidney disease. Ann Intern Med. 2007;147:19\u201327.","journal-title":"Ann Intern Med"},{"key":"1837_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25158135","author":"A-M Visinescu","year":"2024","unstructured":"Visinescu A-M, Rusu E, Cosoreanu A, Radulian G. Cystatin C\u2014a monitoring perspective of chronic kidney disease in patients with diabetes. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25158135.","journal-title":"Int J Mol Sci"},{"key":"1837_CR29","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1080\/0886022X.2022.2134026","volume":"44","author":"P Zhao","year":"2022","unstructured":"Zhao P, Li N, Lin L, Li Q, Wang Y, Luo Y. Correlation between serum cystatin C level and renal microvascular perfusion assessed by contrast-enhanced ultrasound in patients with diabetic kidney disease. Ren Fail. 2022;44:1718\u201326.","journal-title":"Ren Fail"},{"key":"1837_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1185317","author":"Q Jin","year":"2023","unstructured":"Jin Q, Liu T, Qiao Y, et al. Oxidative stress and inflammation in diabetic nephropathy: role of polyphenols. Front Immunol. 2023. https:\/\/doi.org\/10.3389\/fimmu.2023.1185317.","journal-title":"Front Immunol"},{"key":"1837_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-87067-4","author":"EYF Wan","year":"2021","unstructured":"Wan EYF, Yu EYT, Chin WY, et al. Greater variability in lipid measurements associated with kidney diseases in patients with type 2 diabetes mellitus in a 10-year diabetes cohort study. Sci Rep. 2021. https:\/\/doi.org\/10.1038\/s41598-021-87067-4.","journal-title":"Sci Rep"},{"key":"1837_CR32","doi-asserted-by":"publisher","first-page":"20427","DOI":"10.1038\/s41598-023-47449-2","volume":"13","author":"X Su","year":"2023","unstructured":"Su X, Lin S, Huang Y. Value of radiomics-based two-dimensional ultrasound for diagnosing early diabetic nephropathy. Sci Rep. 2023;13:20427.","journal-title":"Sci Rep"},{"key":"1837_CR33","doi-asserted-by":"publisher","first-page":"106169","DOI":"10.1016\/j.cmpb.2021.106169","volume":"207","author":"L Souza-Pereira","year":"2021","unstructured":"Souza-Pereira L, Ouhbi S, Pombo N. Quality-in-use characteristics for clinical decision support system assessment. Comput Methods Programs Biomed. 2021;207:106169.","journal-title":"Comput Methods Programs Biomed"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01837-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-025-01837-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01837-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T06:48:13Z","timestamp":1764917293000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-025-01837-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1837"],"URL":"https:\/\/doi.org\/10.1007\/s10238-025-01837-2","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"assertion":[{"value":"1 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study has been approved by the hospital ethics committee (approval number S2017-152-02). All participants signed a CEUS informed consent form prior to the examination.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"342"}}